Latest Capital Structure News

Viva Leisure has announced a year-long on-market share buy-back program targeting up to 10% of its issued shares, aiming to capitalise on market volatility and reinforce its strong cash flow outlook.

29Metals has successfully completed the retail portion of its entitlement offer, raising $31 million and finalising a $150 million capital injection to support its growth ambitions.

Black Canyon Limited (ASX, BCA) has unveiled promising exploration results and positive scoping studies for its manganese and iron projects in Western Australia, positioning itself as a key emerging developer in the sector.

Deterra Royalties Limited has announced a fully franked ordinary dividend of AUD 0.124 per share for the half-year ending December 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a no-discount option to reinvest.

Osteopore Limited has drawn down the second tranche of its redeemable convertible notes, raising A$500,000 as part of a broader A$20 million funding agreement with Advance Opportunities Fund. The funds are earmarked to support ongoing operations and future growth initiatives.

EDU Holdings has completed a selective buyback of 18 million shares, reducing its issued capital by 12.5% and aiming to boost earnings per share immediately.

Eden Innovations has taken a major step in strengthening its balance sheet by converting a $2.2 million loan into equity, positioning the company debt free and ready to accelerate growth.

Galilee Energy has launched an offer of up to 464 million new options to participants in its recent $6.5 million placement, aiming to bolster exploration funding and working capital. The options, exercisable at $0.011 each over three years, come amid significant operational and market risks.

Global Uranium and Enrichment Limited has been fully acquired by Snow Lake Resources through a share and option scheme, leading to GUE's imminent delisting from the ASX.

Katana Capital Limited has reported a remarkable 672% increase in half-year profit after tax to $5.8 million, driven by strong investment income and gains. The company maintains its quarterly dividend at 0.5 cents per share, reflecting confidence in its ongoing strategy.

AVITA Medical reported a mixed fourth quarter with revenue pressures easing and full-year growth, underpinned by a new $60 million credit facility and advancing clinical trials.

Regal Asian Investments has announced a fully franked interim dividend of 8 cents per share, reflecting robust portfolio returns exceeding 30% over six months. The company also updates its dividend policy to focus on sustainable payouts tied to investment performance.